- Home
- TPZ vs SRTS Comparison
TPZ vs SRTS Comparison
Compare TPZ & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPZ
- SRTS
- Stock Information
- Founded
- TPZ 2007
- SRTS 2010
- Country
- TPZ United States
- SRTS United States
- Employees
- TPZ N/A
- SRTS N/A
- Industry
- TPZ Investment Managers
- SRTS Medical/Dental Instruments
- Sector
- TPZ Finance
- SRTS Health Care
- Exchange
- TPZ Nasdaq
- SRTS Nasdaq
- Market Cap
- TPZ 106.8M
- SRTS 106.0M
- IPO Year
- TPZ N/A
- SRTS 2016
- Fundamental
- Price
- TPZ $20.04
- SRTS $7.64
- Analyst Decision
- TPZ
- SRTS Strong Buy
- Analyst Count
- TPZ 0
- SRTS 2
- Target Price
- TPZ N/A
- SRTS $12.00
- AVG Volume (30 Days)
- TPZ 10.8K
- SRTS 164.1K
- Earning Date
- TPZ 01-01-0001
- SRTS 11-14-2024
- Dividend Yield
- TPZ 8.22%
- SRTS N/A
- EPS Growth
- TPZ N/A
- SRTS N/A
- EPS
- TPZ N/A
- SRTS 0.57
- Revenue
- TPZ N/A
- SRTS $41,308,000.00
- Revenue This Year
- TPZ N/A
- SRTS $55.14
- Revenue Next Year
- TPZ N/A
- SRTS $21.75
- P/E Ratio
- TPZ N/A
- SRTS $13.43
- Revenue Growth
- TPZ N/A
- SRTS 65.62
- 52 Week Low
- TPZ $12.31
- SRTS $2.02
- 52 Week High
- TPZ $15.77
- SRTS $8.29
- Technical
- Relative Strength Index (RSI)
- TPZ 69.92
- SRTS 66.58
- Support Level
- TPZ $19.50
- SRTS $6.70
- Resistance Level
- TPZ $20.40
- SRTS $6.73
- Average True Range (ATR)
- TPZ 0.38
- SRTS 0.43
- MACD
- TPZ 0.08
- SRTS 0.08
- Stochastic Oscillator
- TPZ 81.00
- SRTS 66.49
About TPZ Tortoise Power and Energy Infrastructure Fund Inc
Tortoise Power & Energy Infra Fd Inc is a closed-ended fund. Its primary investment objective is to provide a high level of current income. Its secondary objective is capital appreciation. The company invests in a portfolio of fixed income and equity securities issued by power and energy infrastructure companies.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.